To test this hypothesis, we packaged μGC with melanoma Trp2180‐188, an antigenic peptide shared by murine H‐2Kb and human HLA‐A*0201 major histocompatibility complex (MHC) proteins,[32] and applied the vaccine (μGCTrp2) to treat C57BL/6 mice bearing lung metastatic B16 melanoma (Figure 2a). This evidence concerns the gene HLA-C and melanoma.